Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOLIFE SOLUTIONS INCBLFS · Entity 4614 | Director | August 16, 2021 | August 19, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOLIFE SOLUTIONS INC
Report date August 16, 2021 · Filed August 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,675 |
Reported balance
After 2021-08-16 transaction · row 1
1 source rowRow 1 · 2021-08-16 · Sale · Disposed 2,500 · Balance 17,675 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2021 Filed Aug 19, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $44.51 | $111,275.00 |
DisclosureSEC source: 0001437749-21-020457 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,675 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $44.44 | $111,100.00 |
DisclosureSEC source: 0001437749-21-017103 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,175 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| July 12, 2021 Filed Jul 15, 2021 00:02 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-016944 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,675 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $38.35 | $95,875.00 |
DisclosureSEC source: 0001437749-21-015121 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,675 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| May 17, 2021 Filed May 18, 2021 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $29.06 | $72,650.00 |
DisclosureSEC source: 0001437749-21-012572 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,461 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| April 21, 2021 Filed Jun 5, 2021 00:30 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-21-014195 · rdgdoc.xml · derivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2022-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 21, 2021 Filed Jun 5, 2021 00:30 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.12 | $11,999.68 |
DisclosureSEC source: 0001437749-21-014195 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The number of securities reported in Column 5 is the number of securities beneficially owned as of June 4, 2021. Read SEC document |
| April 15, 2021 Filed Apr 20, 2021 00:54 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 512 | $33.80 | $17,305.60 |
DisclosureSEC source: 0001437749-21-009291 · rdgdoc.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| April 15, 2021 Filed Apr 20, 2021 00:54 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,988 | $33.80 | $67,194.40 |
DisclosureSEC source: 0001437749-21-009291 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,473 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,300 | $37.32 | $48,516.00 |
DisclosureSEC source: 0001437749-21-006376 · rdgdoc.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,461 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,200 | $37.32 | $44,784.00 |
DisclosureSEC source: 0001437749-21-006376 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,761 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $45.67 | $114,175.00 |
DisclosureSEC source: 0001437749-21-003179 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:30 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-020870 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,461 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 00:28 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $17.87 | $107,220.00 |
DisclosureSEC source: 0001437749-19-021119 · rdgdoc.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,461 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| October 08, 2019 Filed Nov 1, 2019 00:28 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001437749-19-021119 · rdgdoc.xml · derivative · entry 3 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2021-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2019 Filed Nov 1, 2019 00:28 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.12 | $11,999.68 |
DisclosureSEC source: 0001437749-19-021119 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2019 Filed Oct 3, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $16.01 | $96,060.00 |
DisclosureSEC source: 0001437749-19-019536 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| August 30, 2019 Filed Aug 31, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $20.07 | $120,420.00 |
DisclosureSEC source: 0001437749-19-017732 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| July 30, 2019 Filed Aug 2, 2019 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $18.82 | $112,920.00 |
DisclosureSEC source: 0001437749-19-015234 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.32 to $19.16 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 01, 2019 Filed Jul 4, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $17.33 | $103,980.00 |
DisclosureSEC source: 0001437749-19-013555 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.69 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 30, 2019 Filed Jun 1, 2019 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $17.50 | $105,000.00 |
DisclosureSEC source: 0001437749-19-011184 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| April 30, 2019 Filed May 2, 2019 20:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 6,000 | $17.19 | $103,140.00 |
DisclosureSEC source: 0001437749-19-008577 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,747 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:02 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 4,000 | $12.05 | $48,200.00 |
DisclosureSEC source: 0001437749-18-022028 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,747 Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · derivative · entry 5 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2020-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 10,714 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · derivative · entry 4 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2019-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 10,000 | $11.25 | $112,500.00 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 3 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,474 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.40 | $15,010.31 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2018 Filed Jun 14, 2018 20:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.26 | $13,510.35 |
DisclosureSEC source: 0001437749-18-011838 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 02:32 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000672 · tv482650_4.xml · nonDerivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,319 F2 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 02:32 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000672 · tv482650_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,381 F1 · shares: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 20:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 997 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-051157 · v476392_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,381 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-036092 · v470491_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,384 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 01:53 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,679 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-019304 · v463690_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,030 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter. Read SEC document |
| February 06, 2017 Filed Feb 10, 2017 00:40 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,857 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001144204-17-007171 · v458956_4.xml · derivative · entry 2 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,857 shares Expires 2017-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2017 Filed Feb 10, 2017 00:40 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 17,857 | $1.12 | $19,999.84 |
DisclosureSEC source: 0001144204-17-007171 · v458956_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:35 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 3,494 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-002793 · v456510_4.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,494 F1 · price: The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.